Unilife: Medical Device Innovator Creating Jobs in PA

Unilife Medical Solutions is an emerging medical device manufacturer with business segments that include pre-filled syringes for pharmaceutical companies to deliver injectable medications, sharps safety devices for healthcare facilities, and contract manufacturing of medical devices.

Read more »

Ligand to Buy Struggling Metabasis

Ligand Pharmaceuticals has agreed to buy the struggling Metabasis Therapeutics for $3.2 million in cash.

Read more »

FDA Calendar November Stocks: Turkeys or a Happy Thanksgiving?

On 10/19/09, BioElectronics (OTC: BIEL.PK) announced the initial results from the pilot section of its ongoing acetaminophen comparison study.

Read more »

OneMedPlace and OneMedForum Enter a Strategic Partnership with MarketWire

OneMedPlace has entered into a partnership with Marketwire, a full-service newswire and communications workflow solutions provider for public relations, investor relations and marketing communications professionals, to accomplish the company’s media outreach goals.

Read more »

Cohera Receives Approval for Surgical Adhesive Trial

Pittsburgh-based Cohera Medical has received approval to begin clinical trials on its TissuGlu surgical adhesive in Europe.

Read more »

Interview with Jeffrey Davis, CEO of Access Pharmaceuticals

OneMedPlace recently interviewed CEO Jeffrey Davis about the Dallas-based company’s pipeline.

Read more »

Zogenix, Astellas Announce Positive Data for Unique Migraine Therapy

Zogenix, a pharmaceutical company specializing in the treatment of chronic pain, and Astellas Pharma have announced positive clinical trial data from two studies of their needle-free migraine treatment system.

Read more »

Osteologix to Continue Development of Osteoporosis Drug

Osteologix is positioning NB S101 as an alternative to traditional osteoporosis treatments.

Read more »

Positive Rheumatoid Arthritis Data for UCB, Trubion, Others

Data presented this weekend at the American College of Rheumatology’s annual meeting indicated that rheumatoid arthritis patients who adhered to a prescription drug regimen had better medical outcomes and lower medical costs.

Read more »

BioDelivery Sciences (NASDAQ: BDSI): Restarting the Catalyst Cycle

BDSI focuses on the niche market of pain management and supportive cancer care.

Read more »